Bruker (BRKR) Current Deferred Revenue (2010 - 2026)

Bruker (BRKR) has reported Current Deferred Revenue for 17 consecutive years, with $555.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue fell 4.86% year-over-year to $555.7 million; the trailing twelve-month figure through Jun 2026 stood at $555.7 million (down 4.86% YoY), and the FY2025 full-year result was $550.4 million, up 2.27% from the prior year.
• Current Deferred Revenue declined to $555.7 million in Q2 2026 per BRKR's latest filing, from $586.1 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $595.8 million in Q2 2024 and bottomed at $381.2 million in Q3 2023.
• Historically, Current Deferred Revenue has averaged $508.3 million across 5 years, with a median of $544.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue decreased 14.98% in 2023, then jumped 49.92% in 2024.
• Over 5 years, Current Deferred Revenue stood at $471.7 million in 2022, then climbed by 4.18% to $491.4 million in 2023, then increased by 9.52% to $538.2 million in 2024, then grew by 2.27% to $550.4 million in 2025, then climbed by 0.96% to $555.7 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $555.7 million, $586.1 million, and $550.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.